Logo
x

Search

Subscribe Now

Certa Therapeutics

Certa Therapeutics’ FT011 Gains the EMA’s Orphan Drug Designation to Treat Systemic Sclerosis

Certa Therapeutics’ FT011 Gains the EMA’s Orphan Drug Designation to Treat Systemic Sclerosis

  • July 22, 2024
Certa Therapeutics’ FT011 Receives the US FDA’s Fast Track Designation for Treating Systemic Sclerosis

Certa Therapeutics’ FT011 Receives the US FDA’s Fast Track Designation for Treating Systemic Sclerosis

  • February 20, 2024
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.